These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10686795)

  • 21. Phenelzine treatment of depression with chronic diarrhea.
    Weiss KJ; Schwartz HJ; Berrettini WH
    J Clin Psychiatry; 1982 Jun; 43(6):250-1. PubMed ID: 7085581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some peculiar aspects of monoamine oxidase inhibition.
    Ramadan ZB; Dostert P; Tipton KF
    Neurobiology (Bp); 1999; 7(2):159-74. PubMed ID: 10591050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB; Perry PJ; Liskow BI; Seaba HH
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
    Gracious BL; Wisner KL
    Depress Anxiety; 1997; 6(3):124-8. PubMed ID: 9442987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical aspects of MAO inhibitor therapy.
    Davidson J; Zung WW; Walker JI
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):81-4. PubMed ID: 6735999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F
    Proc R Soc Med; 1965 Nov; 58(11 Part 2):967-78. PubMed ID: 4952963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.
    Dawson JK; Earnshaw SM; Graham CS
    J Accid Emerg Med; 1995 Mar; 12(1):49-51. PubMed ID: 7640830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction.
    Graham PM; Potter JM; Paterson J
    Lancet; 1982 Aug; 2(8295):440. PubMed ID: 6124828
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.
    Lippman SB; Nash K
    Drug Saf; 1990; 5(3):195-204. PubMed ID: 2190595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myoclonus of probable spinal origin as a potential side effect of tramadol. A case report.
    Isoardo G; Zibetti M; Troni W
    J Neurol; 2005 Jul; 252(7):852. PubMed ID: 15754089
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of MAOI antidepressants.
    Ravaris CL; Robinson DS; Nies A; Ives JO; Bartlett D
    Am Fam Physician; 1978 Jul; 18(1):105-11. PubMed ID: 665471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of homoveratrylamine on the operant behavior of rats. Potentiation by phenelzine.
    Bueno OF; Masur J; Breda JB; Carlini EA
    Acta Physiol Lat Am; 1969; 19(3):181-7. PubMed ID: 5374271
    [No Abstract]   [Full Text] [Related]  

  • 38. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A history of the concept of atypical depression.
    Davidson JR
    J Clin Psychiatry; 2007; 68 Suppl 3():10-5. PubMed ID: 17348762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
    Baker GB; Sowa B; Todd KG
    J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.